The mechanism of antibody-mediated reduction of Haemophilus influenzae type b (Hib) carriage was studied in the infant rat colonization model. Monoclonal Hib polysaccharide (PS) antibody (MAb) given intranasally or intraperitoneally and human secretory anti-Hib PS IgA given intranasally inhibited colonization by Hib during the entire follow-up period (2-48 h after challenge) but did not affect colonization by Hi, a noncapsulated variant of Hib. Ftab'), fragments, prepared from the MAb or from human serum anti-Hib IgG reduced Hib colonization as efficiently as the unc1eaved molecules. Complement depletion by cobra venom treatment had no effect on the antibody-mediated reduction of Hib colonization. These results indicate that Fc-mediated activities of immunoglobulins are not essential in the reduction of Hib colonization. Instead, antibodies to Hib most likely reduce colonization by a direct effect on growth of the bacteria or their adherence to the nasopharyngeal mucosa.
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Haemophilus infiuenzae type b (Hib) polysaccharide (PS)-protein conjugate vaccines reduce oropharyngeal carriage of Hib [1] , which, in tum, reduces transmission and spread ofHib infections. It has been suggested that this reduction leads to herd immunity (i.e., protection of those who have not been vaccinated) [2] .
The mechanism by which conjugate vaccines reduce Hib carriage is not known. We have shown in an infant rat colonization model that intranasally (inl) administered IgG and secretory IgA (sIgA) Hib PS antibodies reduce nasopharyngeal colonization of Hib [3] . Hib colonization also was reduced significantly when IgG anti-Hib PS was given intraperitoneally (ip), if the resultant serum concentration was at least 7 j..lg/mL. In another set of studies, we showed that immunized children had IgG and sIgA Hib PS antibodies in saliva. The IgG antiHib PS concentration in the saliva correlated with that in the serum, suggesting that the salivary IgG was serum derived. By contrast, IgA anti-Hib PS in saliva was most probably produced locally [4] .
The observation that anti-Hib PS antibodies inhibit colonization of Hib is surprising because colonization is thought to be prevented by antibodies directed against adhesins, and the capsule is not known as an adhesin. Coating the surface of the Hib cell with the capsular antibodies may sterically hinder the association of Hib to the epithelium and prevent the growth of Hib [5] . However, complement and phagocytosis may also be involved in the clearance of Hib from the mucosal surface.
In the present study, we used the infant rat model to study the mechanism of anti-Hib PS-mediated inhibition of Hib colonization. We compared the kinetics of colonization of Hib and its noncapsulated variant on the mucosa in the presence of Hib PS antibodies. We also investigated the role of activities mediated by the Fc part of the antibody molecule in the clearance of Hib by using the F(ab')2 fraction of the anti-Hib PS antibody in the colonization experiments. Since antibody-mediated killing of Hib and phagocytosis require complement, the contribution of complement was determined by using complement-depleted infant rats.
Materials and Methods
Outbred, specific pathogen-free albino Wistar rats were obtained from the Animal Center, University of Helsinki. Hib strain 760705b+ (su-R), isolated from cerebrospinal fluid, and its noncapsulated variant Hi 760705bo (Str") [6] were stored in skim milk at -70°C and cultured for animal inoculations as described [3] . The 2 strains have identical reactivities with monoclonal antibody (MAb) specific for lipopolysaccharide and outer membrane proteins PI, P2, P5, and P6. The outer membrane protein and lipopolysaccharide profiles on SDS-PAGE are identical.
Two lots of anti-Hib PS murine MAb E117-5 [7] , containing 800 and 1200 ILg/mL, respectively, of anti-Hib PS IgG lK were used. A control meningococcal porA MAb was received from G. van den Dobbelsteen (RIVM, Netherlands). A human serum IgG fraction containing 36 ILg/mL anti-Hib PS IgG was made from a pooled sample of serum from 10 adults vaccinated with Hib vaccines (half with a polysaccharide and half with a conjugate vaccine) [3] . As a control, IgG fraction containing no detectable anti-Hib PS was made from a pooled sample of serum from children. After immunization, breast milk containing 4.1 p,g/mL of anti-Hib PS, mainly sIgA of the IgAl isotype, was obtained from a mother who had been vaccinated with a Hib conjugate [3] . Preimmunization milk contained <0.2 p,g/mL anti-Hib PS.
Ftab"), fragments were prepared from MAbs and human IgG fractions by pepsin (Merck, Darmstadt, Germany) digestion (pepsin to IgG ratio, 1:2.5 by weight; pepsin to MAb ratio, 1:1 by weight) [8] . Ffab"), fragments were separated from Fe fragments by gel filtration on a Superdex 200 column (Pharmacia LKB Biotechnology, Uppsala, Sweden). The purity of the F(ab')z fractions was confirmed by SDS-PAGE and, in the case of Frah'), from the Mab, by EIA using Fab-and Fe-specific conjugates to mouse IgG (A-3682 and A-9309; Sigma, St. Louis). Fe contamination in Ftab"), fraction from the MAb was 2%, as calculated by comparing the titers of the Mab and the Frab"), derived from the Mab by EIA with an Fe-specific conjugate.
Cobra venom anticomplementary factor (CoVF) from Naja naja kaouthia (C-8406; Sigma) was administered to infant rats by ip injection (0.2 mL/pup, 20 U of CoVFIlOO g of body weight). The activity of complement in serum of CoVF-treated and control animals (given PBS instead ofCoVF) was determined by a complement assay [9] . Results were expressed as titers (reciprocals of dilutions hemolyzing 50% of the sensitized sheep erythrocytes, as estimated by eye). Serum complement titers declined from 16 to < 1 within 3 h after ip injection of CoVF.
Bacteria (~2500 cfu) and antibody were administered inl, as described previously [3] . Antibody was administered 3 h before bacterial challenge, or bacteria were mixed with the antibody just before inoculation. Antibody or PBS (0.15-0.2 mL) were given ip 3 h before administration of bacteria. During follow-up after the injection of 40-55 p,g of MAb/pup, the level of serum antiHib PS remained high (8-12 p,g/mL).
Nasal wash samples were obtained from the infant rats at 6,24, and 48 h or only at 48 h after bacterial challenge. The time point of 48 h was chosen because >90% of pups have been shown to be colonized 48 h after an inl inoculation of 2500 cfu of Hib [3] . The samples were cultured as described [3] , and Hib and Hi colonies were counted. Samples with no colonies « 100 cfu/mL) were assigned a value of 30 cfu/mL. Student's t test, assuming equal variances, was used to compare the geometric mean concentrations (GMC) of Hib or Hi in the groups of animals. P < .05 was considered statistically significant.
Blood samples were taken from the tail vein of unanesthetized pups (pooled samples) or from hearts of CO 2-anesthetized pups (individual samples) to determine anti-Hib PS concentrations by RIA (samples stored at -20°C) or complement depletion (samples stored at -70°C).
Results
In the absence of anti-Hib PS antibodies, the GMC of Hib 760705b+ in nasal wash samples increased from .......,2000 cfu/mL at 2 h to 9800 cfu/mL at 6 h after inl bacterial challenge, at which point it started to decrease slowly, being .......,2000 cfu/ml. When anti-Hib PS murine MAb El17-5 was administered inl (0.12 j.lg/pup) 3 h before bacterial challenge, the number ofHib in nasal wash samples at every time point during followup (2-48 h) was significantly lower than the number in pups that had received PBS (P < .05 at 2 h, P < .01 at 24 h, and P < .001 at 6 and 48 h). This effect was not seen with the Hi strain ( figure 1A, B) .
Similar to the finding with MAbs, Hib colonization was significantly decreased by postimmunization milk (0.08 j.lg of sIgA anti-Hib PS/pup) but not by preimmunization milk during follow-up (P was < .05 at 2 and 48 h, < .01 at 24 h, and < .001 at 6 h). In contrast, the sIgA antibodies had no effect on the colonization of the Hi strain ( figure lC, D) .
At every time point after the ip administration of MAb, the GMC of Hib in nasal wash samples was significantly lower in the group that had received MAb than in the PBS (control) group. For example, at 24 h, the GMC was 1023 cfu/mL for MAb-treated rats and 10834 cfu/mL for PBS-treated rats, and at 48 h, the GMCs were 161 and 1310 cfu/mL, respectively. F(ab')z from MAb and IgG anti-Hib PS reduced Hib colonization as effectively as the uncleaved MAb or anti-Hib PS IgG (P < .001 for each antibody, compared with animals that had received PBS), when administered inl at equimolar concentrations. F(ab')z fragments had no effect on the colonization of the noncapsulated Hi strain (figure 2).
Inl-administered meningococcal MAb, human IgG containing no detectable anti-Hib PS, or Ftab'), fractions from them had no effect on the colonization ofHib (data not shown). In a previous study, we showed that an ip-administered MAb to Chlamydia lipopolysaccharide did not have any effect on the Hib colonization in infant rats [3] .
In the current study, the complement depletion did not interfere with the colonization of Hib and it did not have an effect on MAb-mediated reduction of Hib colonization (figure 2).
Discussion
In the present study we showed that in the presence of mucosal (slgA) or systemic (IgG) Hib PS antibodies, the number of Hib bacteria in nasal wash samples after Hib challenge remained lower than in the absence of antibodies throughout the 2-to 48-h follow-up period. This suggests that anti-Hib PS antibodies prevented either multiplication or adherence of Hib in the nasopharynx.
In in vitro studies by van Alphen et al. [5] , Hib PS antibodies of the IgG class inhibited the adherence ofHib to oropharyngeal epithelial cells, but only at quite high, nonphysiologic concentrations. In those experiments, the Hib dose required was very high, and a lower antibody concentration might be sufficient in vivo, when the infectious dose probably is much smaller. However, much lower Hib PS antibody concentrations, similar to those in serum and saliva after vaccination with Hib conjugate vaccines, inhibited multiplication of Hib in vitro [5] . Mucosal antibodies, especially sIgA, inhibit microbial adherence and colonization by blocking antigenic bacterial surface structures that serve as adhesins. This explanation is not valid for anti-Hib PS, since capsular PS is not known to be an adhesin. However, antibodies may also sterically hinder microbial binding sites, even when directed against a nonadhesive component [5] .
We studied the role of the Fc-mediated activities of the immunoglobulin molecule by using anti-Hib PS molecules from which the Fc part had been eliminated by pepsin digestion; we found that Ftab'), fragments reduced Hib colonization as efficiently as uncleaved molecules. F(ab')2-mediated prevention of bacterial colonization fragments has been studied for Streptococcus mutans [10] and Vibrio cholerae [11] . Local administration of F(ab'h from an S. mutans-specific MAb prevented recolonization of S. mutans in human volunteers; Fab fragments with single antigen binding sites did not have the same effect [10] . In the infant mouse cholera model, Frab"), fragments had the same protective activity against experimental V. cholerae infection as intact IgG, while Fab fragments had a much reduced protective activity [11] . The findings in these two models suggest that cross-linking mediated by intact antibody or its Frab'), fragment is important for the protection of host surfaces against colonization.
Our experiments with complement-depleted animals showed that complement is not essential for MAb-mediated reduction of Rib colonization in infant rats. Whether phagocytosis and complement activation are at all involved in processes on mucosal surfaces is unclear in the absence of knowledge of the presence and concentrations of the necessary complement components at these sites. In the lower respiratory tract, the concentration of complement factor C3 in the epithelial lining fluid in healthy persons is 1% of the serum concentration. In chronic bronchitis patients, the local concentration increases up to 10-fold [12, 13] , which is sufficient for complement-dependent killing of bacteria via the classical route and for C3-mediated opsonophagocytosis [14] . Reynolds et al. [15] showed that both specific sIgA and IgG can promote phagocytosis by human 
